GORE® EXCLUDER® Thoracoabdominal Branch Endoprosthesis (TAMBE)
GORE® EXCLUDER® Thoracoabdominal Branch Endoprosthesis (TAMBE) Bridging the gap between thoracic and abdominal care The first FDA-approved, off-the-shelf, endovascular repair solution for the treatment of complex aneurysmal disease involving the visceral aorta.
GORE RECEIVES FDA APPROVAL FOR BREAKTHROUGH ENDOVASCULAR DEVICE …
Jan 25, 2024 · TAMBE is an implantable branched device designed for use in patients with thoracoabdominal aortic aneurysms (TAAA) and high-surgical risk patients with pararenal aortic aneurysms (PAAA) of the aorta using an endovascular approach in which the physician guides the device through arteries in the groin and arm via small incisions.
Initial Experience With the GORE® EXCLUDER® …
The GORE® EXCLUDER® Thoracoabdominal Branch Endoprosthesis (TAMBE) introduces a novel concept, which is based on the GORE® EXCLUDER® AAA Device platform using a nitinol stent frame and conformable ePTFE technology.
Advancing Endovascular Repair for Thoracoabdominal Aortic …
The TAMBE device is used to offer endovascular treatment for all types of TAAAs and pararenal aneurysms. The study will measure the percentage of uncomplicated technical success with the procedure as well as the percentage of participants who do …
TAMBE is the first and only Food and Drug Administration (FDA) approved, off-the-shelf endovascular device for the treatment of complex aneurysmal disease involving the visceral aorta. 3 NTAP
Early outcomes from the pivotal trial of a four-branch off-the shelf ...
Apr 13, 2024 · Early TAMBE device outcomes demonstrate a high technical success rate, no 30-day lesion-related mortality, and a low rate of safety events within 30 days of the index procedure. Type of Research: Prospective, nonrandomized, multicenter study.
Gore’s Excluder TAMBE Approved by FDA to Treat
Jan 25, 2024 · According to Gore, the Excluder TAMBE is an implantable branched device designed for use in patients with thoracoabdominal aortic aneurysms and high-surgical risk patients with pararenal aortic aneurysms of the aorta.
Intermountain among first to use new aortic aneurysm treatment ...
Oct 16, 2024 · The FDA has approved the Gore EXCLUDER Thoracoabdominal Branch Endoprosthesis (TAMBE) device to treat aortic aneurysms. A surgical team at Intermountain Medical Center was the first outside of clinical trial to deploy the new device and technique.
Yale Surgeons Perform Connecticut’s First FDA-Approved TAMBE …
Aug 19, 2024 · TAMBE offers a groundbreaking, minimally invasive alternative for patients with complex and extensive aneurysms. Surgeons use imaging to guide the TAMBE device through a small incision in the groin, assembling it within the aorta to effectively neutralize the aneurysm.
GORE MEDICAL RECEIVES BREAKTHROUGH DEVICE …
The TAMBE Device is the third Breakthrough Device in the company’s aortic endovascular portfolio to date, following the GORE® TAG® Thoracic Branch Endoprosthesis and the GORE® Ascending Stent Graft, two other investigational devices being developed.